🔎 Trials Near Me

Dachaigh › Lupus

Sgrùdaidhean clionaigeach Lupus a’ fastadh anns na SA

Tha 73 sgrùdaidhean airson Lupus a’ fastadh phàirtichean aig làraichean air feadh nan Stàitean Aonaichte.

Bailtean leis na sgrùdaidhean as motha

Le stàit

Sgrùdaidhean air an ùrachadh o chionn ghoirid

Teacsa sgrùdaidh oifigeil (Beurla)

Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V

A’ fastadhÌre 2
Aoisean 18 gu 100 · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT05268289

A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)

A’ fastadhÌre 2
Aoisean 18 gu 74 · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT07409181

Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).

A’ fastadhÌre 3
Aoisean 12 gu 100 · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT06133972

An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants

A’ fastadhÌre 3
Aoisean 5 gu 17 · Gach gnè · Air ùrachadh 30 Sult 2026 · NCT05835310

Gonadotropin-releasing Hormone Agonist (GnRHa) in Ovarian Preservation in SLE Subjects Receiving Cyclophosphamide as Determined by Questionnaires

A’ fastadhSgrùdadh amharc
Aoisean 18 gu 120 · Banairean · Air ùrachadh 28 Sult 2026 · NCT05567198

A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus

A’ fastadhÌre 3
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT07438496

CD19-Directed Chimeric Antigen Receptor Autologous T Cells (CART19) for Lupus

A’ fastadhÌre 1/2
Aoisean 10 gu 29 · Gach gnè · Air ùrachadh 24 Sult 2026 · NCT06839976

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 23 Sult 2026 · NCT03816345

Anifrolumab Pregnancy Study

A’ fastadhSgrùdadh amharc
Aoisean 18 gu 130 · Banairean · Air ùrachadh 18 Sult 2026 · NCT07049653

The Role of Anifrolumab in Improving Markers of Vascular Risk in Patients With Systemic Lupus Erythematosus (SLE) - IFN-CVD

A’ fastadhÌre 2
Aoisean 18 gu 80 · Gach gnè · Air ùrachadh 18 Sult 2026 · NCT05440422

Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants

A’ fastadhÌre 1
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 18 Sult 2026 · NCT07201558

A Phase IIa Study of ICG318 CAR-T in Refractory Systemic Lupus Erythematosus With or Without Lupus Nephritis

A’ fastadhÌre 2
Aoisean 16 gu 70 · Gach gnè · Air ùrachadh 17 Sult 2026 · NCT07328581

Transcutaneous Vagus Nerve Stimulation in SLE

A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 17 Sult 2026 · NCT06987565

Study of Systemic Lupus Erythematosus

A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
Aoisean 3 gu 120 · Gach gnè · Air ùrachadh 16 Sult 2026 · NCT00001372

HEALTH Home Urinalysis Testing

A’ fastadh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 16 Sult 2026 · NCT07823478

Prospective Registry Investigating Maternal, Infant, and Lactation Outcomes in Anifrolumab Users

A’ fastadhÌre 4
Aoisean 18 gu 130 · Banairean · Air ùrachadh 16 Sult 2026 · NCT06594068

Dose Escalation Study With Bispecific Antibodies in Adult Participants With Lupus Nephritis

A’ fastadhÌre 1
Aoisean 18 gu 60 · Gach gnè · Air ùrachadh 14 Sult 2026 · NCT06975787

A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2)

A’ fastadhÌre 3
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 14 Sult 2026 · NCT07355218

A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Nephritis

A’ fastadhÌre 2
Aoisean 12 gu 70 · Gach gnè · Air ùrachadh 14 Sult 2026 · NCT07570862

A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease

A’ fastadhÌre 3
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 11 Sult 2026 · NCT07332481

A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE

A’ fastadhÌre 1/2
Aoisean 18 gu 70 · Gach gnè · Air ùrachadh 10 Sult 2026 · NCT06897930

Bho ClinicalTrials.gov, dàta air a thogail 5 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.